Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.9bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥11.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥5.5bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥210m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥343m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥203m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥889m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥339m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥79m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥339m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥3m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥613m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥249m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥3m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥249m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥7.7bnat 2022-09-30Cons.Assets
Total assets¥8.6bnat 2022-03-31Cons.Assets
Total assets¥8.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2022-09-30Cons.Liabilities
Total liabilities¥6.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥2.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥2.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥1.6bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.0bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥2.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥45m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥291m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥31m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥151m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥48m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥371m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥696m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥326m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥1.142022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.712022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥228.112021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥92.512021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.872021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio26.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio23.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.7%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥116m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥752m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥746m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥70m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥868m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥867m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥47m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥5.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥12m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥233m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥103,000
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥173m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥591m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥582m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥8m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥51m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥12m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥170m
—segment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
—segment totalsegment profit2021-04-01 → 2021-09-30¥395m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥395m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Decrease increase in inventories ope cfPrior1YTDDuration3594000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-3943000JPY
Decrease increase in accounts receivable other ope cfPrior1YTDDuration-113855000JPY
Decrease increase in accounts receivable other ope cfCurrentYTDDuration-54396000JPY
Decrease increase in other assets ope cfPrior1YTDDuration-10804000JPY
Decrease increase in other assets ope cfCurrentYTDDuration-23555000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-106529000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-537170000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration-10024000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration-21039000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-20819000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration-19903000JPY
Increase decrease in other liabilities ope cfPrior1YTDDuration5797000JPY
Increase decrease in other liabilities ope cfCurrentYTDDuration37262000JPY
Other net ope cfPrior1YTDDuration1230000JPY
Other net ope cfCurrentYTDDuration1012000JPY
Subtotal ope cfPrior1YTDDuration455777000JPY
Subtotal ope cfCurrentYTDDuration208031000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration143000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration132000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-14998000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-9475000JPY
Income taxes paid ope cfPrior1YTDDuration-149612000JPY
Income taxes paid ope cfCurrentYTDDuration-90040000JPY
Income taxes refund ope cfPrior1YTDDuration-JPY
Income taxes refund ope cfCurrentYTDDuration2420000JPY
Payment for special survey costs etc ope cfPrior1YTDDuration-JPY
Payment for special survey costs etc ope cfCurrentYTDDuration-66472000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration291310000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration44595000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-37148000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-26841000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-2759000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-1774000JPY
Proceeds from sales of intangible assets inv cfPrior1YTDDuration127000JPY
Proceeds from sales of intangible assets inv cfCurrentYTDDuration-JPY
Collection of loans receivable inv cfPrior1YTDDuration1372000JPY
Collection of loans receivable inv cfCurrentYTDDuration1383000JPY
Payments for transfer of business2 inv cfPrior1YTDDuration-14000000JPY
Payments for transfer of business2 inv cfCurrentYTDDuration-JPY
Proceeds from transfer of business inv cfPrior1YTDDuration5929000JPY
Proceeds from transfer of business inv cfCurrentYTDDuration-JPY
Payments for lease deposits inv cfPrior1YTDDuration-1905000JPY
Payments for lease deposits inv cfCurrentYTDDuration-4050000JPY
Collection of lease deposits inv cfPrior1YTDDuration50000JPY
Collection of lease deposits inv cfCurrentYTDDuration-JPY
Other net inv cfPrior1YTDDuration109000JPY
Other net inv cfCurrentYTDDuration345000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-48223000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-30938000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass